Skip to main content

Acute Lymphoblastic Leukemia

Rare

Cancer

Acute Lymphoblastic Leukemia is treated with 18 medications in our database, including Clofarabine, MERCAPTOPURINE, Methotrexate, Arranon, Mercaptopurine, and 13 more. 11 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Sanofi, Teva, Pfizer, Novartis, Sebela and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Acute Lymphoblastic Leukemia treatment below.

What help exists for Acute Lymphoblastic Leukemia

25

drugs indexed

15

with copay cards

15

with patient assistance

17

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Acute Lymphoblastic Leukemia

25 total

๐ŸŽŸ = copay card ยท ๐Ÿ’™ = patient assistance program

Prior authorization patterns for Acute Lymphoblastic Leukemia drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

โ€”

Medicare Part D

โ€”โ€”โ€”

Showing 10 of 25 PA rules for Acute Lymphoblastic Leukemia drugs. View individual drug pages for complete PA detail.

Grants for Acute Lymphoblastic Leukemia patients

30 total ยท 17 open

Acute Lymphoblastic Leukemia is a rare disease โ€” more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare โ†’